Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Hung Tae Kim
University of Wisconsin Madison, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Shin Jin Medics Inc
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
An outside activity has a nexus with an individual's research activities if the outside activity arises from, relies upon or is related to the academic expertise that qualifies that individual to participate in federally funded research or human subjects research. The Institution has reasonably determined that the significant financial interest could directly and significantly affect the design, conduct, or reporting of the PHS-funded research and so requires management.
Selective cholecystokinin receptor signaling in the pancreatic islet as therapeutic target against diabetogenic stress
Project Narrative Diabetes mellitus is an unsolved clinical problem with ever-increasing prevalence in the global population. A mechanism-based therapeutic approach to diabetes prevention is necessary to address this epidemic. Identifying drug targets that can specifically promote pancreatic ?-cell survival safely and effectively will add an important new approach to the current diabetes therapies. By identifying direct roles and mechanisms by which cholecystokinin (CCK) signaling promotes ?-cell survival, the completion of the aims in this proposal will open new avenues of investigation for the development of therapies that can selectively agonize the CCK receptors to safely and efficiently improve ?-cell mass and function.
Filed on April 26, 2019.
Tell us what you know about Hung Tae Kim's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.